Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.

Masataka Sawaki,Naruto Taira,Yukari Uemura,Tsuyoshi Saito,Shinichi Baba,Kokoro Kobayashi,Hiroaki Kawashima,Michiko Tsuneizumi,Noriko Sagawa,Hiroko Bando,Masato Takahashi,Miki Yamaguchi,Tsutomu Takashima,Takahiro Nakayama,Masahiro Kashiwaba,Toshiro Mizuno,Yutaka Yamamoto,Hiroji Iwata,Takuya Kawahara,Yasuo Ohashi,Hirofumi Mukai

Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.

2020

PURPOSEAdjuvant trastuzumab monotherapy has not been compared with trastuzumab + chemotherapy. We investigated the relative value of trastuzumab monotherapy for older patients with breast cancer.ME...

Keywords:

Internal medicine
Chemotherapy
Quality of life
early breast cancer
Randomized controlled trial
Breast cancer
older patients
Oncology
Trastuzumab
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations